Minaris Advanced Therapies

End-to-End Cell Therapy Manufacturing / Viral Vector Supply / Testing – CDMO

Goals & Objectives

Minaris Advanced Therapies was formed through the merger of WuXi Advanced Therapies and Minaris Regenerative Medicine, following acquisition by Altaris Capital Partners. With the newly merged entity poised to become a global leader, the company needed a new name, identity, and strategy to reflect its expanded capabilities and global vision.

Digital & SEO

Strategic Approach

That’s Nice developed a visual identity, messaging platform, and go-to-market strategy to position Minaris as a trusted, innovation-driven CDMO in the advanced therapies space. The brand was formally unveiled at ASGCT 2025, providing high-impact visibility at a major industry event.

Inquire About
Project KPIs

Meeting & Exceeding KPIs

The new identity unified legacy organizations under a single banner and helped communicate the company’s end-to-end support model and global infrastructure.